Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Transplantation).php on line 2
Liver (Transplantation)
LE WE PMID CA
Liver (Transplantation)1563Leber (Transplantation)

Antifibrinolytic agents

Autoantibodies ANA

Autoimmune hepatitis

Biliary atresia polysplenia syndrome

CD39

Cystic fibrosis

Deoxyguanosine kinase

Gastrointestinal decontamination

Graft vs host disease

Heme oxygenase

Hemodialysis (BASKET)

Hemolytic uremic syndrome

Hepatic artery

Hepatitis B

Hepatitis C

Immunosuppressive agents

Kidney (Transplantation)

Liver (Artificial)

Liver (Laboratory medicine)

Liver (Neoplasia Hepatoblastoma)

Liver (Neoplasia)

Liver (Regeneration)

Liver (Resection)

Liver (Surgery)

Liver (Transplantation)

Liver (Veinous system)

Novoseven (Activated Factor VII therapeutic use)

Osler Weber Rendu s disease

Porphyria

Urea cycle

1970  
1
Transplantation of the liver in man.
[4909366] Br Med J 1(5696): 585-93 (1970)
2007  
2
Liver transplantation: an update.
[18057459] Neth J Med 65(10): 372-80 (2007)
2005  
3
Hepatocyte transplantation for metabolic liver disease: UK experience.
[16055896] J R Soc Med 98(8): 341-5 (2005)
1999  
4
2008  
5
Chances and risks in living donor liver transplantation.
[19633759] Dtsch Arztebl Int 105(6): 101-7 (2008)
2009  
6
Critical care issues in adult liver transplantation.
[20040807] Indian J Crit Care Med 13(3): 113-9 (2009)
2006  
7
Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria.
[16636009] Alcohol Alcohol 41(4): 358-63 (2006)
2009  
8
2004  
9
Split liver transplantation.
[18333054] HPB (Oxford) 6(2): 76-82 (2004)
2004  
10
Techniques of orthotopic liver transplantation.
[18333053] HPB (Oxford) 6(2): 69-75 (2004)
1991  
11
Infections following orthotopic liver transplantation.
[1650245] HPB Surg 3(4): 221-32; discussion 232-3 (1991)
1991  
12
Pediatric liver transplantation.
[2043513] HPB Surg 3(3): 145-66 (1991)
1998  
13
Liver transplantation for fulminant hepatic failure in the pediatric patient.
[9711957] Arch Surg 133(8): 839-46 (1998)
2003  
14
Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period.
[12724633] Ann Surg 237(5): 666-75; discussion 675-6 (2003)
2001  
15
A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.
[11524591] Ann Surg 234(3): 384-93; discussion 393-4 (2001)
1999  
16
Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
[10363896] Ann Surg 229(6): 824-31; discussion 831-3 (1999)
1999  
17
Split liver transplantation.
[10077042] Ann Surg 229(3): 313-21 (1999)
1998  
18
Complications in 100 living-liver donors.
[9712567] Ann Surg 228(2): 214-9 (1998)
1998  
19
Guidelines for surgical procedures after liver transplantation.
[9563551] Ann Surg 227(4): 590-9 (1998)
1998  
20
Biliary atresia-polysplenia syndrome: surgical and clinical relevance in liver transplantation.
[9563550] Ann Surg 227(4): 583-9 (1998)
1993  
21
Effect of the 21-aminosteroid tirilazad on cerebral pH and somatosensory evoked potentials after incomplete ischemia.
[8488529] Stroke 24(5): 724-30 (1993)
1997  
22
Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report.
[9114793] Ann Surg 225(4): 355-64 (1997)
1997  
23
Liver transplantation for metastatic neuroendocrine tumors.
[9114792] Ann Surg 225(4): 347-54 (1997)
1997  
24
Proceed with caution: liver transplantation for metastatic neuroendocrine tumors.
[9114791] Ann Surg 225(4): 345-6 (1997)
1996  
25
Split-liver transplantation. The Paul Brousse policy.
[8968228] Ann Surg 224(6): 737-46; discussion 746-8 (1996)
1996  
26
In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool.
[8813261] Ann Surg 224(3): 331-9; discussion 339-41 (1996)
2007  
27
Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease.
[17593061] Aliment Pharmacol Ther 26(2): 141-8 (2007)
2007  
28
Review article: the treatment of hepatitis C virus recurrence after liver transplantation.
[17593060] Aliment Pharmacol Ther 26(2): 127-40 (2007)
2007  
29
Review article: medical management of the liver transplant recipient - a primer for non-transplant doctors.
[17217455] Aliment Pharmacol Ther 25(3): 229-45 (2007)
2006  
30
Review article: hepatitis B and liver transplantation.
[16611263] Aliment Pharmacol Ther 23(8): 1031-41 (2006)
2004  
31
Review article: current status of liver transplantation in HIV-infected patients.
[15569101] Aliment Pharmacol Ther 20(10): 993-1000 (2004)
2002  
32
Review article: adult-to-adult right hepatic lobe living donor liver transplantation.
[12390092] Aliment Pharmacol Ther 16(11): 1833-41 (2002)
1985  
33
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen.
[3881037] Am J Pathol 118(1): 151-61 (1985)
1999  
34
Diagnosis and management of late complications after liver transplantation.
[10519725] Arch Dis Child 81(5): 446-51 (1999)
1998  
35
Who needs a liver transplant? (new disease specific indications).
[10193265] Arch Dis Child 79(5): 460-4 (1998)
1992  
36
2004  
37
Developments in liver transplantation.
[15082598] Gut 53(5): 759-68 (2004)
2007  
38
Early post-operative complications in living donor liver transplantation: prevention, detection and management.
[17690027] Hepatobiliary Pancreat Dis Int 6(4): 345-7 (2007)
2005  
39
Split liver transplantation: a reliable approach to expand donor pool.
[16109512] Hepatobiliary Pancreat Dis Int 4(3): 339-44 (2005)
2007  
40
Liver transplantation for metabolic liver diseases in adults: indications and outcome.
[17890269] Nephrol Dial Transplant 22 Suppl 8(-): viii9-viii12 (2007)
2009  
41
Overview of immunosuppression in liver transplantation.
[19750565] World J Gastroenterol 15(34): 4225-33 (2009)
2009  
42
Interventional radiology procedures in adult patients who underwent liver transplantation.
[19222091] World J Gastroenterol 15(6): 684-93 (2009)
2009  
43
2009  
44
2008  
45
Cardiac evaluation of liver transplant candidates.
[18567069] World J Gastroenterol 14(22): 3445-51 (2008)
2008  
46
Transplantation in autoimmune liver diseases.
[18528936] World J Gastroenterol 14(21): 3388-95 (2008)
2007  
47
Current role of bloodless liver resection.
[17352009] World J Gastroenterol 13(6): 826-9 (2007)
2006  
48
Liver biopsy interpretation for causes of late liver allograft dysfunction.
[16871565] Hepatology 44(2): 489-501 (2006)
2005  
49
AASLD practice guidelines: Evaluation of the patient for liver transplantation.
[15880505] Hepatology 41(6): 1407-32 (2005)
2000  
50
Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury.
[10915720] Hepatology 32(2): 169-73 (2000)
2000  
51
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel.
[10706577] Hepatology 31(3): 792-9 (2000)
1997  
52
Banff schema for grading liver allograft rejection: an international consensus document.
[9049215] Hepatology 25(3): 658-63 (1997)
2009  
53
Interventional radiology procedures in pediatric patients with complications after liver transplantation.
[19325066] Radiographics 29(2): 567-84 (2009)
2007  
54
Complications of liver transplantation: multimodality imaging approach.
[17848699] Radiographics 27(5): 1401-17 (2007)
2006  
55
Pediatric liver transplantation: a pictorial essay of early and late complications.
[16844941] Radiographics 26(4): 1187-209 (2006)
2005  
56
Multidetector CT in the evaluation of potential living donors for liver transplantation.
[16009821] Radiographics 25(4): 1017-30 (2005)
2004  
57
Evaluation of living liver transplant donors: method for precise anatomic definition by using a dedicated contrast-enhanced MR imaging protocol.
[15256620] Radiographics 24(4): 957-67 (2004)
2003  
58
US of liver transplants: normal and abnormal.
[12975502] Radiographics 23(5): 1093-114 (2003)
2001  
59
Spectrum of CT findings in pediatric patients after partial liver transplantation.
[11158644] Radiographics 21(1): 53-63 (2001)
2001  
60
Use of imaging for living donor liver transplantation.
[11158643] Radiographics 21(1): 39-52 (2001)
1993  
61
Imaging in pediatric liver transplantation.
[8210591] Radiographics 13(5): 1081-99 (1993)
2010  
62
Postoperative imaging in liver transplantation: what radiologists should know.
[20228321] Radiographics 30(2): 339-51 (2010)
2007  
63
Sonographic diagnosis and outcome of hepatic artery thrombosis after orthotopic liver transplantation in adults.
[17646460] AJR Am J Roentgenol 189(2): 346-51 (2007)
2007  
64
Sonographic evaluation of venous obstruction in liver transplants.
[17515341] AJR Am J Roentgenol 188(6): W515-21 (2007)
2011  
65
Pre operative cardio pulmonary assessment of the liver transplant candidate.
[21911881] Ann Hepatol 10(4): 421-33 (2011)
2006  
66
Clinicopathologic findings and outcomes of liver transplantation using grafts from donors with unrecognized and unusual diseases.
[16447189] Liver Transpl 12(2): 310-5 (2006)
2006  
67
Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation.
[16628694] Liver Transpl 12(5): 707-9 (2006)
2006  
68
Pediatric liver transplantation: past, present, and future.
[16555337] Liver Transpl 12(4): 511-3 (2006)
2006  
69
Live donor liver transplantation.
[16555328] Liver Transpl 12(4): 499-510 (2006)
2006  
70
Histologic findings in recurrent HBV.
[17051563] Liver Transpl 12(11 Suppl 2): S50-3 (2006)
2006  
71
Model for end-stage liver disease (MELD) exception guidelines.
[17123285] Liver Transpl 12(12 Suppl 3): S85-7 (2006)
2006  
72
Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.
[17123284] Liver Transpl 12(12 Suppl 3): S128-36 (2006)
2006  
73
Recurrence of autoimmune liver disease after liver transplantation: a systematic review.
[17031826] Liver Transpl 12(12): 1813-24 (2006)
2002  
74
Identification of patients best suited for combined liver-kidney transplantation: part II.
[11910564] Liver Transpl 8(3): 193-211 (2002)
2002  
75
Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I.
[11862584] Liver Transpl 8(2): 91-109 (2002)
2002  
76
Prioritization of patients with liver cancer within the MELD system.
[11965575] Liver Transpl 8(4): 329-30 (2002)
2010  
77
Post-liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria.
[21031537] Liver Transpl 16(11): 1228-35 (2010)
2010  
78
Hepatitis B after transplantation: competition between the recipient virus and the donor virus.
[21031536] Liver Transpl 16(11): 1225-7 (2010)
2010  
79
Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management.
[20440764] Liver Transpl 16(5): 550-7 (2010)
2005  
80
2005  
81
Endoscopic management of the liver transplant patient.
[16123974] Liver Transpl 11(9): 1007-21 (2005)
2005  
82
Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University.
[16237708] Liver Transpl 11(11): 1332-42 (2005)
2005  
83
Kidney dysfunction in the recipients of liver transplants.
[16237714] Liver Transpl -(11 Suppl 2): S47-51 (2005)
2005  
84
Roles and pitfalls of transplantation in human porphyria.
[16315299] Liver Transpl 11(12): 1460-2 (2005)
2005  
85
Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center.
[16184521] Liver Transpl 11(11): 1370-8 (2005)
2005  
86
Chronic allograft dysfunction: diagnosis and management. Is it always progressive?
[16237682] Liver Transpl -(11 Suppl 2): S63-8 (2005)
2005  
87
When is diabetes mellitus a relative or absolute contraindication to liver transplantation?
[16237683] Liver Transpl -(11 Suppl 2): S25-9 (2005)
2005  
88
Immunosuppression in liver transplantation.
[16237688] Liver Transpl 11(11): 1307-14 (2005)
2005  
89
The role of liver transplantation in cystic fibrosis re-examined.
[16315291] Liver Transpl 11(12): 1463-5 (2005)
2004  
90
Liver transplantation in patients with hepatocellular carcinoma.
[14762845] Liver Transpl 10(2 Suppl 1): S81-5 (2004)
2004  
91
Post-liver-transplant anemia: etiology and management.
[14762852] Liver Transpl 10(2): 165-73 (2004)
2004  
92
Hepatic arterial anatomy for right liver procurement from living donors.
[14755790] Liver Transpl 10(1): 134-5 (2004)
2004  
93
Nontumoral dermatologic problems after liver transplantation.
[15004757] Liver Transpl 10(3): 331-9 (2004)
2004  
94
Older age and liver transplantation: a review.
[15390320] Liver Transpl 10(8): 957-67 (2004)
2004  
95
The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta-analysis.
[15237363] Liver Transpl 10(7): 817-27 (2004)
2004  
96
Selective decontamination of the digestive tract: rationale behind evidence-based use in liver transplantation.
[15237364] Liver Transpl 10(7): 828-33 (2004)
2005  
97
Antifibrinolytics in orthotopic liver transplantation: current status and controversies.
[15690531] Liver Transpl 11(1): 10-8 (2005)
2003  
98
Evaluation of the donor liver for living donor liver transplantation.
[14528424] Liver Transpl 9(10 Suppl 2): S16-28 (2003)
2003  
99
Surgical techniques used in adult living donor liver transplantation.
[14528425] Liver Transpl 9(10 Suppl 2): S29-34 (2003)
2003  
100
Hepatic regeneration in living donor liver transplantation.
[14528426] Liver Transpl 9(10 Suppl 2): S35-41 (2003)
2003  
101
Early and late complications in the right-lobe adult living donor.
[14528428] Liver Transpl 9(10 Suppl 2): S45-9 (2003)
2003  
102
The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients.
[14586892] Liver Transpl 9(11): S28-34 (2003)
2003  
103
Intrahepatic cholestasis after liver transplantation.
[14526393] Liver Transpl 9(10): 1005-18 (2003)
2003  
104
Selection of donors for living donor liver transplantation.
[14528421] Liver Transpl 9(10 Suppl 2): S2-7 (2003)
2007  
105
Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT).
[17539003] Liver Transpl 13(6): 838-43 (2007)
2007  
106
Liver transplantation for porphyria: who, when, and how?
[17763398] Liver Transpl 13(9): 1219-27 (2007)
2005  
107
Immunosuppression in liver transplantation: beyond calcineurin inhibitors.
[15719409] Liver Transpl 11(3): 267-80 (2005)
2005  
108
Management of pre-liver transplantation patient--part 2.
[15719412] Liver Transpl 11(3): 249-60 (2005)
2005  
109
Nonischemic cardiomyopathy after orthotopic liver transplantation: a report of three cases and a review of the literature.
[15838869] Liver Transpl 11(5): 573-8 (2005)
2005  
110
Liver transplantation with monosegments. Technical aspects and outcome: a meta-analysis.
[15838874] Liver Transpl 11(5): 564-9 (2005)
2005  
111
Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data.
[15838886] Liver Transpl 11(5): 525-31 (2005)
2009  
112
Pulmonary hypertension after liver transplantation: case presentation and review of the literature.
[19326402] Liver Transpl 15(4): 407-12 (2009)
2008  
113
Critical use of extended criteria donor liver grafts in adult-to-adult whole liver transplantation: a single-center experience.
[18236398] Liver Transpl 14(2): 220-7 (2008)
2008  
114
How accurately and how early can we predict rapid fibrosis progression in hepatitis C virus-infected patients after liver transplantation?
[18756466] Liver Transpl 14(9): 1237-9 (2008)
2008  
115
Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens.
[18756456] Liver Transpl 14(9): 1249-55 (2008)
2008  
116
Predicting the viability of liver allografts procured from non-heart-beating donors: the role of histopathology.
[18756448] Liver Transpl 14(9): 1240-2 (2008)
2008  
117
Bile duct stones and casts after liver transplantation: Different entities but similar prevention strategy?
[18825732] Liver Transpl 14(10): 1400-3 (2008)
2008  
118
The natural history of recurrent hepatitis C and what influences this.
[18825724] Liver Transpl 14 Suppl 2(-): S36-44 (2008)
2008  
119
Liver transplantation for hepatitis B: what is the best hepatitis B immune globulin/antiviral regimen?
[18825721] Liver Transpl 14 Suppl 2(-): S15-22 (2008)
2008  
120
How to diagnose and treat hepatitis B virus antiviral drug resistance in the liver transplant setting.
[18825720] Liver Transpl 14 Suppl 2(-): S8-S14 (2008)
2008  
121
Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency.
[18825706] Liver Transpl 14(10): 1480-5 (2008)
2008  
122
Auxiliary transplantation for acute liver failure: Histopathological study of native liver regeneration.
[18825705] Liver Transpl 14(10): 1437-48 (2008)
2008  
123
Temporary portocaval shunt in orthotopic liver transplantation: need for a standardized approach?
[18825702] Liver Transpl 14(10): 1414-9 (2008)
2008  
124
Biliary cast syndrome following liver transplantation: Predictive factors and clinical outcomes.
[18825683] Liver Transpl 14(10): 1466-72 (2008)
2008  
125
Central perivenulitis: a common and potentially important finding in late posttransplant liver biopsies.
[18433067] Liver Transpl 14(5): 596-600 (2008)
2008  
126
Plasma cell hepatitis in liver allografts: Variant of rejection or autoimmune hepatitis?
[18508366] Liver Transpl 14(6): 750-5 (2008)
2005  
127
Liver transplantation for cardiac failure in patients with hereditary hemorrhagic telangiectasia.
[15973723] Liver Transpl 11(7): 834-8 (2005)
2009  
128
Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.
[19876939] Liver Transpl 15 Suppl 2(-): S25-34 (2009)
2006  
129
A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation.
[16799946] Liver Transpl 12(7): 1049-61 (2006)
2011  
130
How to protect liver graft with nitric oxide.
[21734799] World J Gastroenterol 17(24): 2879-89 (2011)
2011  
131
Dual protective role of HO-1 in transplanted liver grafts: a review of experimental and clinical studies.
[21912452] World J Gastroenterol 17(26): 3101-8 (2011)
2010  
132
Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.
[20503446] World J Gastroenterol 16(20): 2468-75 (2010)
2007  
133
Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation.
[17278187] World J Gastroenterol 13(5): 657-70 (2007)
2009  
134
Liver transplantation for hepatocellular carcinoma.
[19938188] World J Gastroenterol 15(44): 5511-6 (2009)
2003  
135
Recent advances in liver transplantation.
[12583530] Mayo Clin Proc 78(2): 197-210 (2003)
2009  
136
Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.
[19092117] J Am Soc Nephrol 20(5): 940-9 (2009)
2006  
137
Chronic kidney disease post-liver transplantation.
[16735393] Nephrol Dial Transplant 21(9): 2630-6 (2006)
2011  
138
Recipient outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis.
[21283553] PLoS One 6(1): e16521 (2011)
2011  
139
Calcineurin-inhibitor minimization in liver transplant patients with calcineurin-inhibitor-related renal dysfunction: a meta-analysis.
[21931704] PLoS One 6(9): e24387 (2011)
2011  
140
Prophylactic activated recombinant factor VII in liver resection and liver transplantation: systematic review and meta-analysis.
[21818342] PLoS One 6(7): e22581 (2011)
2004  
141
Paediatric liver transplantation: the surgical view.
[15466990] Postgrad Med J 80(948): 571-6 (2004)
2006  
142
Adult-to-adult living donor liver transplantation.
[16691300] Can J Gastroenterol 20(5): 339-43 (2006)
2011  
143
Long-term results of liver transplantation.
[21482501] Scand J Surg 100(1): 14-21 (2011)
2006  
144
Liver transplantation in children.
[16735759] Indian Pediatr 43(5): 389-91 (2006)
2005  
145
A review of aprotinin in orthotopic liver transplantation: can its harmful effects offset its beneficial effects?
[15845662] Anesth Analg 100(5): 1248-55 (2005)
2004  
146
Liver transplantation in patients with hepatocellular carcinoma: factors implicated in tumor relapse.
[14971994] Rev Esp Enferm Dig 96(1): 22-31 (2004)
2008  
147
The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.
[17981736] Front Biosci 13(-): 2588-603 (2008)
2004  
148
Transplanted liver: consequences of denervation for liver functions.
[15382009] Anat Rec A Discov Mol Cell Evol Biol 280(1): 924-31 (2004)
2008  
149
Artificial circulation of the liver: machine perfusion as a preservation method in liver transplantation.
[18484620] Anat Rec (Hoboken) 291(6): 735-40 (2008)
2008  
150
Live donors in liver transplantation.
[18471556] Gastroenterology 134(6): 1802-13 (2008)
2004  
151
Revolution and refinement of surgical techniques for living donor partial liver transplantation.
[15627300] Yonsei Med J 45(6): 1076-88 (2004)
2008  
152
Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?
[19060534] Curr Opin Organ Transplant 13(5): 506-12 (2008)
2006  
153
Liver retransplantation: report of 80 cases and review of literature.
[16698571] Hepatobiliary Pancreat Dis Int 5(2): 180-4 (2006)
2007  
154
2010  
155
2007  
156
MELD score, step forward to justice of liver graft allocation in Brazil.
[18060268] Arq Gastroenterol 44(3): 187-8 (2007)
2009  
157
A comprehensive review of immunosuppression used for liver transplantation.
[20130772] J Transplant 2009(-): 701464 (2009)
2011  
158
Value of T-tube in biliary tract reconstruction during orthotopic liver transplantation: a meta-analysis.
[21528489] J Zhejiang Univ Sci B 12(5): 357-64 (2011)
2010  
159
Small for size syndrome following living donor and split liver transplantation.
[21206720] World J Gastrointest Surg 2(12): 389-94 (2010)
PMC   
160
Induction of antinuclear antibodies by de novo autoimmune hepatitis regulates alloimmune responses in rat liver transplantation.
[24454474] Clin Dev Immunol 2013():413928 (2013)
PMC   
161
Early respiratory complications after liver transplantation.
[24409054] World J Gastroenterol 19(48):9271-81 (2013)
PMC   
162
Long-term survival after liver transplantation for alcoholic liver disease.
[24409048] World J Gastroenterol 19(48):9198-208 (2013)
PMC   
163
Re-examination of sinusoidal deposition of complement 4d in liver allografts: experience from a single institution.
[24551304] Int J Clin Exp Pathol 7(2):784-91 (2014)
PMC   
164
Long term outcomes after pediatric liver transplantation.
[24511516] Pediatr Gastroenterol Hepatol Nutr 16(4):207-18 (2013)
PMC   
165
Surgical text for orthotopic liver transplantation model with small-for-size graft in the pig: key techniques and pitfalls.
[24714270] Ann Gastroenterol 25(2):147-161 (2012)
PMC   
166
The evolution in the prioritization for liver transplantation.
[24713804] Ann Gastroenterol 25(1):6-13 (2012)
PMC   
167
The utility of the SOFA score for predicting mortality in critically ill cirrhotic patients receiving liver transplantation.
[23591045] Crit Care 17(2):426 (2013)
PMC   
168
Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine.
[24696621] Hepat Med 5():1-10 (2013)
PMC   
169
Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials.
[24765218] Hepatol Int 8(2):198-215 (2014)
PMC   
170
Suppression of graft regeneration, not ischemia/reperfusion injury, is the primary cause of small-for-size syndrome after partial liver transplantation in mice.
[24709852] PLoS One 9(4):e93636 (2014)
PMC   
171
HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.
[24744588] World J Gastroenterol 20(14):3986-4000 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Transplantation).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Transplantation).php on line 92